6 completed, 1 recruiting, 1 unknown. 5 Phase 1, 3 Phase 2.
By phase and status
Follow Glaceum: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
A Study to Assess the Efficacy and Safety of Vutiglabridin in Knee Osteoarthritis Patients Vutiglabridin, Placebo - Knee Osteoarthritis (Knee OA) | Phase 2 | Recruiting | 60 | 2025-08-19 | 2025-08-15 |
A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients Vutiglabridin, Placebo - Parkinson Disease | Phase 2 | Completed | 99 | 2024-07-22 | 2026-07-08 |
A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HGR4113 in Healthy Subjects HGR4113, Placebo - Diabetes Mellitus, Type 2 | Phase 1 | Unknown | 40 | 2022-11-22 | 2024-03-21 |
A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HSG4112 in High Doses HSG4112, Placebo - Obesity | Phase 1 | Completed | 36 | 2022-04-21 | 2024-03-20 |
A Study to Evaluate the Safety and Efficacy of HSG4112 in Overweight and Obese Patients HSG4112, Placebo - Obesity | Phase 2 | Completed | 81 | 2022-02-24 | 2024-03-19 |
A Study to Investigate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of HSG4112 HSG4112, Placebo - Obesity | Phase 1 | Completed | 40 | 2021-02-15 | 2022-09-09 |
A Study to Investigate the Effect of Food on the Pharmacokinetics of HSG4112 HSG4112 - Obesity | Phase 1 | Completed | 12 | 2020-07-12 | 2021-09-24 |
A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics, and Food Effect of HSG4112 HSG4112, Placebo - Obesity | Phase 1 | Completed | 90 | 2018-08-23 | 2021-11-01 |
Conditions studied
Obesity (5) · Diabetes Mellitus, Type 2 (1) · Osteoarthritis, Knee (1) · Parkinson Disease (1)
Countries
South Korea (8)
Top investigators
Kyung Sang Yu, MD, PhD (2) · Hyuktae Kwon, MD, PhD (1) · Young-Ran Yoon (1)
Results publications
PMID 37693914